Form 4: Pelosi Reports USANA Health Sciences Stock Transactions

Peggie Pelosi, a Director at USANA Health Sciences Inc., has reported transactions involving restricted stock units and common stock.

Summary

• Director Peggie Pelosi reported the acquisition of 1,057 restricted stock units (RSUs) on April 23, 2026.
• These RSUs represent a contingent right to receive one share of USANA common stock.
• Pelosi also reported the disposition of 668 shares of common stock for $19.24 per share on April 23, 2026.
• Following these transactions, Pelosi beneficially owns 6,032 shares of common stock directly.
• The RSUs vest in four equal installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions without significant positive or negative implications for the company's immediate financial health or strategic direction.

Positives

• Acquisition of 1,057 restricted stock units indicates continued equity-based compensation and potential future ownership.
• The vesting schedule for RSUs suggests a long-term incentive plan for the director.

Negatives

• Disposition of 668 shares of common stock may indicate a partial divestment by the director.

Future Outlook

The vesting schedule for the restricted stock units indicates future potential increases in beneficial ownership for the director, contingent on continued service.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions in publicly traded companies, providing transparency into executive and director holdings and activities within the health sciences and nutritional supplement industry.

Stakeholder Impact

• Shareholders: Increased transparency into director's equity holdings and transactions.

Next Steps

• Vesting of remaining restricted stock units on scheduled dates.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Restricted Stock Units, Common Stock, Director Transactions, Beneficial Ownership